Global Pharmaceutical Activated Carbon Market Growth 2023-2029

Global Pharmaceutical Activated Carbon Market Growth 2023-2029

The global Pharmaceutical Activated Carbon market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Activated charcoal has been used as an oral medicine for a long time, and in the rescue and treatment of patients with acute transoral poisoning, medicinal activated charcoal is one of the important basic rescue measures, which can obviously reduce the absorption of poison and increase the excretion and removal of poison, and obviously improve the success rate of rescue of patients with transoral poisoning. Oral administration of activated carbon is an effective method to reduce the absorption of poisons taken by patients. As an excellent adsorbent material, activated carbon is not only used for oral adsorption and detoxification in emergency medicine, but also widely used as a blood perfusion adsorbent for artificial organ adsorption preparations, for specific central nervous system, for treating certain previously incurable diseases, and in recent years it has also been used as a drug carrier for solutes, for treating malignant tumors Lymph nodes, for guiding the removal of metastatic lymph nodes, and for adjust the pore size of activated carbon and its distribution so that it can absorb various harmful substances and bacteria.

Units: The units in this report refer to the basic quantity units of statistics, such as tablets (Changtian Pharmaceuticals) for the tablet type, and capsules and pills for the pill type, such as Wuxi Ji Yu Shanhe Pharmaceuticals. The unit of product for bag type or granule type is bag.

The key manufacturers of pharmaceutical activated carbon in the Chinese market are Jemincare, Changtian Pharma, Kureha, Myvitamins, etc. The top two manufacturers account for 99% of the market share, with the largest manufacturer being Jemincare with 89%. Production areas are mainly located in Europe, China, Japan, etc. In terms of product type, activated carbon tablets/granules occupy the major market share, accounting for 90%, followed by activated carbon capsules, accounting for about 10%. In terms of application, the pharmacy channel is the top application area, accounting for 70% of the total, while the prescription channel accounts for 28%.

LPI (LP Information)' newest research report, the “Pharmaceutical Activated Carbon Industry Forecast” looks at past sales and reviews total world Pharmaceutical Activated Carbon sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Activated Carbon sales for 2023 through 2029. With Pharmaceutical Activated Carbon sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Activated Carbon industry.

This Insight Report provides a comprehensive analysis of the global Pharmaceutical Activated Carbon landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Activated Carbon portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pharmaceutical Activated Carbon market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Activated Carbon and breaks down the forecast by type, by distribution channel, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Activated Carbon.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Activated Carbon market by product type, distribution channel, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Pharmaceutical Activated Carbon Capsule
Pharmaceutical Activated Carbon Tablet
Others

Segmentation by distribution channel
Drug Stores
Prescription Drug

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Jemincare
Changtian Pharma
Kureha
Myvitamins

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pharmaceutical Activated Carbon market?

What factors are driving Pharmaceutical Activated Carbon market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pharmaceutical Activated Carbon market opportunities vary by end market size?

How does Pharmaceutical Activated Carbon break out type, distribution channel?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.